Cite
MLA Citation
S. Tolaney et al.. “Patients' quality of life and side effect perceptions in monarchE, a study of abemaciclib plus endocrine therapy in adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer.” Breast, vol. 56, n.d., pp. S20–S21. http://access.bl.uk/ark:/81055/vdc_100123992816.0x000024